Dr. Tareq Abadl: Low-Titer Group O Whole Blood – Faster, Simpler Resuscitation for Severe Hemorrhage
Tareq Abadl, Medical Laboratory Specialist and Director of the Blood Bank at Dr. Abdelkader Al-Mutawakkil Hospital, shared a post on LinkedIn:
“Low-Titer Group O Whole Blood (LTOWB)
Faster, simpler resuscitation for severe hemorrhage
What it is
Whole blood from low-titer group O donors, containing RBCs + plasma + platelets in a single unit. Can be issued immediately when patient blood type is unknown—critical in massive bleeding.
Why it matters in trauma care?
- Speed: One product, rapid release → shorter time to first transfusion
- Physiology: Delivers balanced hemostatic resuscitation from the start
Evidence: Observational studies and cohort analyses link earlier LTOWB with lower early mortality and faster resuscitation vs component therapy
- Operational advantages
- Simplified logistics: Replace multiple components with one unit
- Prehospital-ready: Suits EMS, aeromedical, and austere settings
- Inventory efficiency: Streamlined storage and deployment pathways
Safety and evidence status
Reassuring safety signals in civilian use so far
Ongoing RCTs clarifying superiority vs equivalence to components
- Key policy decisions:
Anti-A/B titer thresholds
Leukoreduction strategy
Hemovigilance and outcome tracking
Supply balance to avoid shortages
- Practical implementation notes
- Define indications: Major hemorrhage, prehospital trauma, MTP entry
- Specify product: Titer limits, leukoreduction (if used), storage conditions
- Train teams: Ordering, handling, documentation (ED, OR, EMS)
- Coordinate early: Transfusion committee + regional blood services
Bottom line
LTOWB is a pragmatic, evidence-informed tool that shortens time to transfusion and simplifies hemorrhage resuscitation. It complements—not replaces—component therapy. Adoption should be guided by local epidemiology, supply logistics, and formal policy.

Read more from Dr. Tareq Abadl on Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health